For Federally Qualified Health Centers (FQHCs) and other Covered Entities, the 340B Program is more than a regulatory requirement: it is a financial lifeline. However, a significant number of entities are currently operating with “leakage” that drains their potential savings. In the industry, we often refer to the 340B capture rate as the ultimate barometer of a program’s health. If your capture rate is stagnant or declining, your entity is likely leaving hundreds of thousands of dollars on the table: funds that should be directed toward expanding patient services and improving health outcomes.
The challenge is that capture rate optimization is not a singular task; it is a multi-disciplinary effort involving technology, provider education, and clinical operations. When these gears stop turning in unison, the result is a compliance and financial nightmare.
Below, we examine the ten most common reasons why your 340B capture rate may be failing and, more importantly, the methodical steps you must take to fix them.
1. Referral Leakage: The “Black Hole” of Prescriptions
The single largest contributor to a low capture rate is referral leakage. When your providers refer a patient to an outside specialist, the resulting prescription is often written by a provider not currently in your system’s “eligible” database. Without a robust referral tracking system, these prescriptions are frequently missed by your Third-Party Administrator (TPA), resulting in lost 340B savings.
The Fix: Implement a “closed-loop” referral management system. Ensure that every specialist consult includes a plan to receive the consultation note back into your EHR. By documenting the specialist’s note, you establish the “patient-provider relationship” required under HRSA guidelines, allowing you to capture those high-value specialty prescriptions.
2. Disconnected Technology and Data Silos
Many entities rely on legacy IT infrastructures that do not communicate with one another. If your EHR, your In-House Pharmacy Management System, and your Contract Pharmacy TPA are not integrated, data visibility becomes impossible. This lack of transparency means you cannot identify where prescriptions are being sent or why they aren’t being captured as 340B eligible.
The Fix: Invest in Advanced Analytics and Program Dashboards. Real-time data integration allows you to see exactly where “leakage” is occurring at a provider or pharmacy level. As noted by industry experts, a robust technology solution is essential for capturing savings across all dispensing channels [1].
3. The Provider Knowledge Gap
It is a common misconception that 340B is solely a “pharmacy problem.” In reality, capture begins in the exam room. If your clinicians do not understand which pharmacies are in your contract network, or why it matters where they send a script, they cannot help direct the patient toward the most cost-effective option.
The Fix: Conduct quarterly provider education sessions. Use your performance dashboards to show providers their individual capture rates. Framing 340B as a “patient access tool” rather than a “finance tool” often increases clinical buy-in.
4. Inadequate Patient Education and Engagement
Patients often choose pharmacies based on convenience, habit, or proximity. If they are unaware that filling their prescription at your in-house pharmacy or a specific contract pharmacy helps fund their own care, they have no incentive to change their behavior.
The Fix: Use point-of-care education. Simple signage, brochures, and verbal cues from nursing staff can significantly shift patient behavior. Highlighting the lower out-of-pocket costs available through 340B pricing is a powerful motivator for your uninsured and underinsured populations.
5. In-House Pharmacy Operational Friction
If your In-House Pharmacy has long wait times, limited hours, or frequent stock-outs of common medications, patients will naturally drift toward larger retail chains. Every script that leaves your four walls is a missed opportunity for higher-margin capture.
The Fix: Audit your pharmacy workflow. Consider implementing “Meds-to-Beds” programs or mail-order options to increase convenience. Enhancing the operational performance of your pharmacy is often the fastest way to see an immediate uptick in capture rates.
6. Misaligned Contract Pharmacy Networks
Many entities set up their Contract Pharmacy networks years ago and haven’t looked at them since. If your patient demographics have shifted, or if a high-volume retail chain has changed its 340B policies, your current network may be geographically or strategically irrelevant.
The Fix: Perform a geographic “heat map” analysis of where your patients live and where your providers’ scripts are currently going. Prune pharmacies with low capture rates and high administrative fees, and target new pharmacies that align with your patient flow.
7. Manufacturer Restrictions and 340B ESP Friction
In 2024 and 2025, pharmaceutical manufacturers have significantly increased restrictions on contract pharmacies, often requiring detailed claims-level data through platforms like 340B ESP. If your entity is not submitting this data accurately or timely, manufacturers may block 340B pricing entirely, causing your capture rate (and revenue) to plummet.
The Fix: Automate your Manufacturer Compliance & 340B ESP Management. Manual data entry is a recipe for disaster. Professional oversight ensures that your data is compliant and that you maintain access to 340B pricing across your entire network.
8. Staff Turnover and Regulatory Fatigue
The 340B program is incredibly complex. When a key staff member: such as a 340B Coordinator or a Pharmacy Director: leaves, institutional knowledge often goes with them. This leads to neglected reporting, missed audits, and a gradual decay in program performance.
The Fix: Partner with a dedicated 340B consultant to act as a permanent extension of your team. This provides continuity and ensures that your program remains optimized regardless of internal staffing changes.
9. Inventory Management Complexity
Managing inventory for clinic-administered medications versus retail prescriptions is a logistical hurdle. Inadvertent drug diversion or simple tracking errors can result in medications being overlooked and not billed through the 340B program [1].
The Fix: Implement rigorous compliance frameworks and internal audits. Regular inventory reconciliation is not just about compliance; it’s about ensuring every eligible dispense is accounted for.
10. Lack of Actionable Real-Time Insights
If you are only looking at your 340B savings once a quarter, you are “flying blind.” You cannot fix a capture rate problem that you didn’t know existed until three months after the fact.
The Fix: Transition to a proactive management model. Use consolidated dashboards that integrate claims from all vendors, providing financial performance tracking and capture rate analytics in real-time. This allows for strategic decision-making based on current data, not historical artifacts.
Conclusion: Taking the Next Step
Optimizing your 340B capture rate is not a one-time project; it is a continuous process of refinement. The financial health of your health center depends on your ability to navigate these complexities with precision.
At GapRx 340B Consultants LLC, we specialize in identifying these exact gaps. Whether it’s automating your 340B ESP submissions, optimizing your in-house pharmacy operations, or providing the advanced analytics you need to stop referral leakage, we are here to ensure your program achieves its full potential.
Are you ready to stop the leakage and maximize your savings?
Schedule a consultation with our expert team today to receive a comprehensive audit of your 340B program performance.
References: [1] 340B Program Challenges for FQHCs: IT Infrastructure and Inventory Complexity. RxInsider Industry Insights (2024). [2] Contract Pharmacy Participation and Regulatory Pressures. AAFCpa Healthcare Perspectives (2024).